US Stock MarketDetailed Quotes

SAB Biotherapeutics (SABS)

Watchlist
  • 3.860
  • -0.040-1.03%
Close Apr 14 16:00 ET
  • 4.000
  • +0.140+3.63%
Post 16:55 ET
271.26MMarket Cap-4.89P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SAB Biotherapeutics (SABS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.08%48.95M
57.56%15.77M
12.11%12.68M
-4.60%9.73M
-5.43%10.77M
12.70%42.91M
-46.97%10.01M
112.47%11.31M
57.52%10.2M
53.89%11.39M
Selling and administrative expenses
4.43%14.6M
103.97%5.04M
6.62%3.71M
-24.91%2.74M
-25.65%3.11M
-41.25%13.98M
-83.39%2.47M
35.33%3.48M
25.61%3.64M
21.52%4.19M
-General and administrative expense
4.43%14.6M
103.97%5.04M
6.62%3.71M
-24.91%2.74M
-25.65%3.11M
-41.25%13.98M
-83.39%2.47M
35.33%3.48M
25.61%3.64M
21.52%4.19M
Research and development costs
13.56%34.35M
40.21%10.73M
14.55%8.97M
2.56%7M
-6.00%7.66M
83.18%30.25M
78.05%7.65M
94.81%7.83M
86.29%6.82M
79.60%8.15M
Other operating expenses
----
----
----
----
----
40.94%-1.32M
62.40%-114.7K
----
-207.70%-263.14K
-62.55%-944.58K
Operating profit
-14.08%-48.95M
-57.56%-15.77M
-12.11%-12.68M
4.60%-9.73M
5.43%-10.77M
-12.70%-42.91M
46.97%-10.01M
-112.47%-11.31M
-57.52%-10.2M
-53.89%-11.39M
Net non-operating interest income expense
23.13%1.19M
872.97%637.28K
207.29%611.94K
-118.04%-50.78K
-101.68%-7.07K
258.79%967.6K
-83.87%65.5K
459.87%199.14K
701.98%281.44K
1,325.46%421.52K
Non-operating interest income
11.36%1.43M
413.84%700.74K
136.40%655.23K
-96.38%13.56K
-87.45%62.5K
119.84%1.29M
-71.83%136.37K
1,829.64%277.17K
1,211.11%374.56K
758.61%497.89K
Non-operating interest expense
-24.41%240.66K
-10.46%63.46K
-44.52%43.29K
-30.90%64.35K
-8.91%69.57K
0.99%318.4K
-8.99%70.88K
11.96%78.04K
23.63%93.12K
-17.33%76.37K
Other net income (expense)
678.75%61.04M
-19.05%-1.73M
7,459.30%57.51M
-112.82%-331.43K
-6.07%5.58M
278.61%7.84M
66.93%-1.45M
175.72%760.82K
822.99%2.58M
7,096.56%5.94M
Gain on sale of security
1,065.35%62.75M
-41.06%-3.25M
998,099.77%61.6M
-128.28%-627.06K
-7.91%5.04M
211.65%5.39M
51.21%-2.31M
-96.55%6.17K
720.10%2.22M
6,521.24%5.47M
Other non- operating income (expenses)
-170.07%-1.72M
78.44%1.53M
-641.50%-4.09M
-19.63%295.63K
15.05%546.63K
463.70%2.45M
153.03%855K
676.52%754.65K
--367.83K
--475.13K
Income before tax
138.92%13.27M
-47.97%-16.86M
539.11%45.45M
-37.88%-10.11M
-3.40%-5.2M
19.17%-34.11M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
Income tax
Net income
138.92%13.27M
-47.97%-16.86M
539.11%45.45M
-37.88%-10.11M
-3.40%-5.2M
19.17%-34.11M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
Net income continuous Operations
138.92%13.27M
-47.97%-16.86M
539.11%45.45M
-37.88%-10.11M
-3.40%-5.2M
19.17%-34.11M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
Minority interest income
Net income attributable to the parent company
138.92%13.27M
-47.97%-16.86M
539.11%45.45M
-37.88%-10.11M
-3.40%-5.2M
19.17%-34.11M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
138.92%13.27M
-47.97%-16.86M
539.11%45.45M
-37.88%-10.11M
-3.40%-5.2M
19.17%-34.11M
50.15%-11.39M
-102.84%-10.35M
-6.61%-7.34M
31.66%-5.03M
Basic earnings per share
105.98%0.22
71.21%-0.3541
144.64%0.5
-37.97%-1.09
-3.70%-0.56
51.83%-3.68
68.05%-1.23
-15.46%-1.12
41.91%-0.79
63.01%-0.54
Diluted earnings per share
78.53%-0.79
-34.67%-1.6564
81.25%-0.21
-37.97%-1.09
-3.70%-0.56
51.83%-3.68
68.05%-1.23
-15.46%-1.12
41.91%-0.79
63.01%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.08%48.95M57.56%15.77M12.11%12.68M-4.60%9.73M-5.43%10.77M12.70%42.91M-46.97%10.01M112.47%11.31M57.52%10.2M53.89%11.39M
Selling and administrative expenses 4.43%14.6M103.97%5.04M6.62%3.71M-24.91%2.74M-25.65%3.11M-41.25%13.98M-83.39%2.47M35.33%3.48M25.61%3.64M21.52%4.19M
-General and administrative expense 4.43%14.6M103.97%5.04M6.62%3.71M-24.91%2.74M-25.65%3.11M-41.25%13.98M-83.39%2.47M35.33%3.48M25.61%3.64M21.52%4.19M
Research and development costs 13.56%34.35M40.21%10.73M14.55%8.97M2.56%7M-6.00%7.66M83.18%30.25M78.05%7.65M94.81%7.83M86.29%6.82M79.60%8.15M
Other operating expenses --------------------40.94%-1.32M62.40%-114.7K-----207.70%-263.14K-62.55%-944.58K
Operating profit -14.08%-48.95M-57.56%-15.77M-12.11%-12.68M4.60%-9.73M5.43%-10.77M-12.70%-42.91M46.97%-10.01M-112.47%-11.31M-57.52%-10.2M-53.89%-11.39M
Net non-operating interest income expense 23.13%1.19M872.97%637.28K207.29%611.94K-118.04%-50.78K-101.68%-7.07K258.79%967.6K-83.87%65.5K459.87%199.14K701.98%281.44K1,325.46%421.52K
Non-operating interest income 11.36%1.43M413.84%700.74K136.40%655.23K-96.38%13.56K-87.45%62.5K119.84%1.29M-71.83%136.37K1,829.64%277.17K1,211.11%374.56K758.61%497.89K
Non-operating interest expense -24.41%240.66K-10.46%63.46K-44.52%43.29K-30.90%64.35K-8.91%69.57K0.99%318.4K-8.99%70.88K11.96%78.04K23.63%93.12K-17.33%76.37K
Other net income (expense) 678.75%61.04M-19.05%-1.73M7,459.30%57.51M-112.82%-331.43K-6.07%5.58M278.61%7.84M66.93%-1.45M175.72%760.82K822.99%2.58M7,096.56%5.94M
Gain on sale of security 1,065.35%62.75M-41.06%-3.25M998,099.77%61.6M-128.28%-627.06K-7.91%5.04M211.65%5.39M51.21%-2.31M-96.55%6.17K720.10%2.22M6,521.24%5.47M
Other non- operating income (expenses) -170.07%-1.72M78.44%1.53M-641.50%-4.09M-19.63%295.63K15.05%546.63K463.70%2.45M153.03%855K676.52%754.65K--367.83K--475.13K
Income before tax 138.92%13.27M-47.97%-16.86M539.11%45.45M-37.88%-10.11M-3.40%-5.2M19.17%-34.11M50.15%-11.39M-102.84%-10.35M-6.61%-7.34M31.66%-5.03M
Income tax
Net income 138.92%13.27M-47.97%-16.86M539.11%45.45M-37.88%-10.11M-3.40%-5.2M19.17%-34.11M50.15%-11.39M-102.84%-10.35M-6.61%-7.34M31.66%-5.03M
Net income continuous Operations 138.92%13.27M-47.97%-16.86M539.11%45.45M-37.88%-10.11M-3.40%-5.2M19.17%-34.11M50.15%-11.39M-102.84%-10.35M-6.61%-7.34M31.66%-5.03M
Minority interest income
Net income attributable to the parent company 138.92%13.27M-47.97%-16.86M539.11%45.45M-37.88%-10.11M-3.40%-5.2M19.17%-34.11M50.15%-11.39M-102.84%-10.35M-6.61%-7.34M31.66%-5.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 138.92%13.27M-47.97%-16.86M539.11%45.45M-37.88%-10.11M-3.40%-5.2M19.17%-34.11M50.15%-11.39M-102.84%-10.35M-6.61%-7.34M31.66%-5.03M
Basic earnings per share 105.98%0.2271.21%-0.3541144.64%0.5-37.97%-1.09-3.70%-0.5651.83%-3.6868.05%-1.23-15.46%-1.1241.91%-0.7963.01%-0.54
Diluted earnings per share 78.53%-0.79-34.67%-1.656481.25%-0.21-37.97%-1.09-3.70%-0.5651.83%-3.6868.05%-1.23-15.46%-1.1241.91%-0.7963.01%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +8.11%
Sample Name
Sample Code
 +7.67%
Sample Name
Sample Code
 +5.06%
4
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.18%
5
United States Gasoline Fund Lp
UGA
+2.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +26.23%
Sample Name
Sample Code
 +21.09%
Sample Name
Sample Code
 +18.00%
4
Hesai
HSAI
+16.00%
5
Futu Holdings Ltd
FUTU
+14.80%
View More
Middle East conflict spreads to the stock market! How should investors respond?
At 22:00 Beijing time on April 13, the US Central Command officially blocked maritime traffic at Iranian ports, imposing the strictest sanct Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -